Vigonvita Life Sciences
唯久生物
Vigonvita Life Sciences
Biotech/Healthcare
Weijiu Biotech is dedicated to discovering, developing, and commercializing innovative therapies for age-related debilitating diseases caused by inflammation and tissue fibrosis, including renal interstitial fibrosis, idiopathic pulmonary fibrosis, and systemic sclerosis. The company focuses its…
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.